HR - NYSE

Healthcare Realty Trust Incorporated

HR·NYSE

$19.58

+0.077%

Real EstateREIT - Healthcare Facilities

Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September 30, 2020, the Company owned 211 real estate properties in 24 states totaling 15.5 million square feet and was valued at approximately $5.5 billion. The Company provided leasing and property management services to 11.9 million square feet nationwide.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$6.87B

EPS-0.7100

P/E Ratio-27.58

Earnings Date07/30/2026

457.10M

Operating Cash Flow

-9%

3Y+68.0%

5Y-3.0%

10Y+202.0%

710.83M

Investing Cash Flow

-21%

3Y-57.0%

5Y-228.0%

10Y-399.0%

-1.21B

Financing Cash Flow

-11%

3Y-35.0%

5Y-1314.0%

10Y-984.0%

Healthcare Realty Trust Incorporated Cash Conversion Engine

HR · NYSE

FCF Components

Net Income-246.07M

Depreciation & Amortization567.32M

Stock-Based Compensation22.39M

Change in Working Capital-32.29M

Others145.75M

Capital Expenditures-330.15M

Free Cash Flow126.94M

Cash Flow Quality Analysis

FCF Conversion Rate

-51.6%

Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.

CapEx Intensity

72.2%

Very high capital intensity consumes most operating cash flow. Limited flexibility for dividends or debt reduction.

FCF Growth Trend

-49.8%

Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.

Working Capital Impact

-$32.29M

Moderate working capital outflow. Typical for growing businesses, but ensure it's supporting revenue growth, not inefficiency.

Cash Flow Quality Insight

Deteriorating cash generation: Both declining FCF and weak conversion rate signal fundamental challenges. Investigate margin pressure, rising costs, or working capital issues.

Healthcare Realty Trust Incorporated Cash Flow Statement

HR • NYSE

Healthcare Realty Trust Incorporated Cash Flow Statement	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
OPERATING ACTIVITIES
Net Income	-246.1M	-663.9M	-282.1M	40.7M	66.7M	72.2M	39.2M	69.8M	23.1M	85.6M	69.4M	32.2M	7M	5.5M	-184K	8.2M	51.1M	41.7M	60.1M	39.7M
Depreciation & Amortization	567.3M	722.3M	775.9M	477.8M	206.5M	194.8M	180.9M	167.2M	146.4M	131M	120.4M	116M	105.3M	101.4M	92.4M	77.9M	70.9M	54.7M	53.9M	65.5M
Change in Deferred Taxes	0.0	0.0	0.0	0.0	0.0	-48.2M	-19.1M	-41.4M	11M	-40.9M	-34.4M	2.8M	13.8M	4M	1.6M	-770K	-674K	1.5M	-40.5M	0.0
Stock-Based Compensation	22.4M	31.8M	14.3M	20.3M	10.7M	9.9M	12.3M	10.7M	10M	7.6M	6M	4.5M	5.2M	3.5M	2.9M	2.4M	3.7M	2.8M	96K	0.0
Other Non-Cash Items	145.7M	437.2M	62.6M	-233.3M	-42.7M	242.2M	-1.5M	-2.8M	-4.6M	-7.1M	-3.6M	-10.3M	-8.2M	-73K	-4.3M	-5.5M	-26.1M	7.2M	12.2M	8M
Change in Working Capital	-32.3M	-25.9M	-70.9M	-32.8M	-8.5M	-851K	1.4M	4.9M	-6.1M	-24.9M	2.6M	-19.8M	-2.3M	2M	12.6M	-1.5M	4.2M	-1.3M	5.2M	-4.1M
Cash from Operating Activities	457.1M	501.6M	499.8M	272.7M	232.6M	470.1M	213.1M	208.4M	179.8M	151.3M	160.4M	125.4M	120.8M	116.4M	105M	80.8M	103.2M	106.6M	90.9M	109.1M
INVESTING ACTIVITIES
Investments in Property, Plant, and Equipment	(0.0)	-249M	-231M	-163.5M	-100.7M	-94M	-64.7M	-70.8M	-80.6M	-71.4M	-48.8M	-70.7M	-72.8M	-22.9M	-230.1M	-369M	-170.5M	-383.7M	-130.8M	-126.3M
Acquisitions, Net	(0.0)	(0.0)	-3.8M	(1.1B)	-89.6M	-65.7M	(1.2M)	(0.0)	-8.7M	-4.6M	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	-184K	(882K)	(0.0)	(126.3M)
Purchase of Investments	(0.0)	(0.0)	(0.0)	(0.0)	-186.4M	-268.4M	-581.4M	-51.7M	-2.5B	-592M	-279.6M	(0.0)	(0.0)	(0.0)	-101.9M	-25.1M	-23.4M	-42.5M	(0.0)	-10.7M
Sale/Maturity of Investments	0.0	0.0	0.0	0.0	0.0	23.8M	5.6M	305.8M	93M	27.5M	34.6M	0.0	2.7M	0.0	0.0	0.0	148.9M	8.2M	311.9M	32.7M
Other Investing Items	710.8M	1.1B	584M	738M	-185.8M	-151M	220.7M	-34.2M	-170.1M	-166.4M	-17M	-34.9M	-137.9M	-90.3M	37.4M	43.7M	-52.6M	48.2M	52.2M	-75.6M
Cash from Investing Activities	(710.8M)	(900.9M)	(349.1M)	(1.6B)	-562.5M	-555.2M	-418.5M	-105M	-259.4M	-237.8M	-65.8M	-105.6M	-207.9M	-113.3M	-294.7M	-350.4M	-97.8M	-368.9M	(233.4M)	-53.5M
FINANCING ACTIVITIES
Net Issuance of Common Stock	-4M	-519.2M	-2.2M	19.7M	327.3M	140.6M	290.8M	-3.9M	246.9M	448.7M	65.6M	66.8M	219.8M	202.3M	251.8M	118.2M	26.5M	197M	70.4M	86K
Net Issuance of Debt	-796.6M	-375.5M	-404.2M	-457.2M	176.3M	131.9M	201.8M	53.2M	-69.1M	-175.4M	-28.8M	34.6M	-15.9M	-107M	-77M	-44.5M	26M	143.7M	-59.6M	77M
Cash Paid for Dividends	-386.9M	-457.9M	-472.2M	-1.4B	-175.5M	-275.8M	-256.1M	-150.3M	-142.3M	-131.8M	-120.3M	-116.4M	-111.6M	-96.4M	-89.3M	-75.8M	-91.4M	-81.3M	-101.1M	-126.2M
Share Repurchases	-4M	-519.3M	-2.3M	-3.2M	-3.8M	-1.4M	-5.1M	-4.5M	-1.7M	-1.8M	-1.4M	-10.1M	-454K	-68K	-86K	-51.9M	-8K	-282K	(0.0)	(0.0)
Other Financing Items	-23.2M	-6.8M	-5.7M	-14.4M	-405K	245.1M	-38.9M	-7M	244.5M	-4.6M	231.5M	66.9M	216.9M	387.7M	4.8M	379M	563.4M	-156K	-227.4M	-11.5M
Cash from Financing Activities	-1.2B	-1.4B	-884.2M	-1.9B	327.7M	99.7M	197.7M	-101.2M	31.4M	137M	-94M	-24.9M	89M	-1.1M	81.1M	377.1M	-3.7M	257.9M	-317.7M	-60.6M
CASH FLOW SUMMARY
Effect of Foreign Exchange Rates	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8M	141.8M	-52.2M	2.1M	-2.5M	230K	-55.6M	148.8M	-297.2M	89M	127.2M	0.0	0.0
Net Change in Cash	-42.7M	43.2M	-35.3M	47.8M	-2.1M	14.6M	-7.7M	2.2M	-48.3M	50.4M	583K	-5.2M	1.9M	2M	-108.6M	107.5M	1.7M	-4.4M	6.6M	-5.1M
Cash at Beginning of Period	68.9M	25.7M	61M	13.2M	15.3M	657K	8.4M	6.2M	54.5M	4.1M	3.5M	8.7M	6.8M	4.7M	113.3M	5.9M	4.1M	8.5M	2M	7M
Cash at End of Period	26.2M	68.9M	25.7M	61M	13.2M	15.3M	657K	8.4M	6.2M	54.5M	4.1M	3.5M	8.7M	6.8M	4.7M	113.3M	5.9M	4.1M	8.5M	2M
Free Cash Flow	126.9M	252.6M	268.8M	109.2M	131.9M	376.1M	148.5M	137.5M	99.2M	79.8M	111.6M	54.7M	48M	93.5M	-125.1M	-288.2M	-67.3M	-277.1M	-39.9M	-17.3M

SEC Filings

HR - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 20, 2026	May 20, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 19, 2026	May 19, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 07, 2026	May 07, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 01, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 30, 2026	April 30, 2026	2026	View Filing
DEF 14A DEF 14A 2025 N/A	April 07, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 27, 2026	February 27, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 23, 2026	February 19, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 13, 2026	December 31, 2025	2025	View Filing

Showing 1 to 10 of 633 filings

Related Guides

Blog Categories

Continue your HR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.